Maza-Solano, J.; Calvo-Henríquez, C.; Alobid, I.; Álvarez-Cendrero, M.; Palomares, Ó.; Moreno-Luna, R.; Santos-Perez, J.; González-García, J.; Sánchez-Gómez, S.
Nasal Symptoms in Asthmatic Patients under Treatment with Anti-IL-5 Monoclonal Antibodies. A Real-Life Cohort Study. J. Clin. Med. 2022, 11, 7056.
https://doi.org/10.3390/jcm11237056
AMA Style
Maza-Solano J, Calvo-Henríquez C, Alobid I, Álvarez-Cendrero M, Palomares Ó, Moreno-Luna R, Santos-Perez J, González-García J, Sánchez-Gómez S.
Nasal Symptoms in Asthmatic Patients under Treatment with Anti-IL-5 Monoclonal Antibodies. A Real-Life Cohort Study. Journal of Clinical Medicine. 2022; 11(23):7056.
https://doi.org/10.3390/jcm11237056
Chicago/Turabian Style
Maza-Solano, Juan, Christian Calvo-Henríquez, Isam Alobid, Marta Álvarez-Cendrero, Óscar Palomares, Ramón Moreno-Luna, Jaime Santos-Perez, Jaime González-García, and Serafín Sánchez-Gómez.
2022. "Nasal Symptoms in Asthmatic Patients under Treatment with Anti-IL-5 Monoclonal Antibodies. A Real-Life Cohort Study" Journal of Clinical Medicine 11, no. 23: 7056.
https://doi.org/10.3390/jcm11237056
APA Style
Maza-Solano, J., Calvo-Henríquez, C., Alobid, I., Álvarez-Cendrero, M., Palomares, Ó., Moreno-Luna, R., Santos-Perez, J., González-García, J., & Sánchez-Gómez, S.
(2022). Nasal Symptoms in Asthmatic Patients under Treatment with Anti-IL-5 Monoclonal Antibodies. A Real-Life Cohort Study. Journal of Clinical Medicine, 11(23), 7056.
https://doi.org/10.3390/jcm11237056
